Description of Medical ServiceWhole genome sequencing (WGS) is a genetic test that sequences genes in both mitochondrial (mtDNA) and nuclear genome (nDNA) in a single test. Once Mitochondrial Disease (MD) is suspected a request for WGS would be made. The WGS results are then examined, looking for variants in genes known to be associated with MD.
Description of Medical ConditionMitochondria are known as the ‘powerhouse of the cell’. They are responsible for producing energy that the cells can use. Mitochondrial disease (MD) limits the ability for the mitochondria to produce energy and is caused by genetic variations (faults) in the genes that make up the mitochondria. Given mitochondria exist in cells all over the body there are hundreds of different types of MD, depending on the severity, location and number of mitochondria affected. This means MD has varying effects and on the functioning of the body and therefore presents differently among affected individuals. MD is often a debilitating disease and potentially fatal, resulting in poor mobility, coordination, weakness and fatigue.
Reason for ApplicationNew MBS item
Medical Service TypeInvestigative technology
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 1955 KB)
Application Form (Word 1815 KB)
Consultation SurveyConsultation Survey (PDF 690 KB)
Consultation Survey (Word 72 KB)
PASC consultation closed
MSAC consultation input must be received by no later than Friday, 7 October 2022 for it to be considered by MSAC at its November 2022 meeting.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO ConfirmationPICO Confirmation (PDF 2579 KB)
PICO Confirmation (Word 1203 KB)